Unlocking the Power of the Genome
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illumina | Sequencing and array solutions to fuel genomic discoveries
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Minos Biosciences biotech, deeptech, Biotechnology Research | Other 15 May 2024 | | ||
Speedinvest Venture Capital and Private Equity Principals | Other 31 Mar 2024 | | ||
Automata industry 4.0, Automation Machinery Manufacturing | Other 2 May 2024 | | ||
Oroxcell biotech, deeptech, Biotechnology Research | Other 3 Apr 2024 | | ||
Invest Victoria Government Administration | Other 29 Apr 2024 | | ||
Diatech Pharmacogenetics biotech, deeptech, Biotechnology Research | Other 22 Apr 2024 | | ||
La Synapse Government Administration | Other 29 Feb 2024 | | ||
The Naked Scientists entertainment, Media Production | Other 12 Apr 2024 | | ||
British In Vitro Diagnostics Association (BIVDA) healthtech, Hospitals and Health Care | Other 2 Apr 2024 | | ||
National Center for APEC it services, International Trade and Development | Other 31 Jan 2024 | |